PR Premier

NAARI AG has presented the new product which stimulates more efficient metabolism for estrogen for the Russian pharmaceutical market.

The new biologically active supplement BALANCID which promotes a health estrogen metabolism was launched in Moscow on June, 19th.

NAARI AG has presented the new product which stimulates more efficient metabolism for estrogen for the Russian pharmaceutical market.

NAARI is a Swiss pharmaceutical company which is integrated in research, development, manufacturing and marketing of female hormones.

Qualities of Balancid absolutely correspond to these principles: the given food supplement is a source of digestible microencapsulated DIM - a substance that promotes the normalization of hormonal level and increase "good" estrogen in the female body.

Speakers of the event:

  • Dr. V.Е.Balan, professor, senior researcher at the Department of Gynecological Endocrinology, Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology", Ministry of Healthcare and Social Development of the Russian Federation; vice-President of the Russian association of menopause;
  • Dr. Michael A.Zeligs, Founder and CEO BioResponse LLC;
  • Dr.Manfred Paul, director CIS-operations, Naari AG.

The event was attended by journalists of the leading glossy and specialized medical media, as well as doctors-gynecologists.

Organization and realization of the event were carried out by PR-Premier agency.

Client: Naari